The supplement millions swallow nightly for better sleep might deliver less than promised—and carry risks few consumers know about.

Story Snapshot

• Melatonin supplements show measurable benefits only for specific conditions like jet lag and circadian rhythm disorders, not general insomnia
• A 2017 study found 71% of melatonin supplements contained dosages off by more than 10%, with some varying up to 478%
• Recent research links long-term melatonin use to 90% higher heart failure risk and 3.5 times greater hospitalization odds
• The American Academy of Sleep Medicine recommends against using melatonin for insomnia maintenance despite widespread consumer use
• While short-term use appears safe in small doses, quality control problems and emerging cardiovascular concerns challenge the supplement’s reputation

The Gap Between Marketing and Medical Consensus

Walk down any pharmacy aisle and melatonin bottles promise natural, effective sleep solutions. The reality proves far more complicated. The American Academy of Sleep Medicine issues clear guidance: melatonin works for circadian rhythm disorders like jet lag, but evidence remains weak for treating common insomnia. This distinction matters because most consumers buy melatonin specifically for everyday sleep struggles—the exact use case lacking strong scientific support. A 2021 meta-analysis of 23 randomized controlled trials did find improvements in Pittsburgh Sleep Quality Index scores, yet those gains appeared strongest in people with respiratory and metabolic disorders, not the general population tossing and turning at night.

What Your Bottle Might Actually Contain

The supplement industry operates under looser regulations than prescription medications, and melatonin illustrates this problem perfectly. Researchers analyzing commercial melatonin products in 2017 discovered a troubling pattern: 71% of tested supplements contained actual melatonin levels differing from labels by more than 10%. Some products contained up to 478% more melatonin than advertised. Others included serotonin, a controlled substance, despite no mention on labels. This variability means consumers cannot reliably know what dose they’re taking—a significant concern when even small amounts affect brain chemistry. The lack of FDA oversight for supplement accuracy leaves buyers gambling on both effectiveness and safety with every purchase.

Emerging Cardiovascular Concerns Challenge Long-Term Use

Recent research from cohort studies tracking over 130,000 adults reveals a darker side to prolonged melatonin use. People taking melatonin for insomnia longer than one year showed heart failure rates of 4.6% compared to 2.7% in non-users—a 90% increased risk. Hospitalization odds jumped even higher, with 19% of long-term users requiring inpatient care versus 6.6% of those avoiding the supplement, representing 3.5 times greater risk. These findings from 2023-2025 analyses employed rigorous methodology, requiring at least two prescriptions 90 days apart to confirm consistent use. The cardiovascular system appears vulnerable to chronic melatonin exposure in ways short-term studies never captured, raising serious questions about treating a benign sleep complaint with a substance potentially harming the heart.

When Melatonin Actually Delivers Results

Dismissing melatonin entirely ignores legitimate applications where evidence supports its use. Travelers crossing time zones find genuine relief with doses between 0.5mg and 5mg, as multiple trials confirm improvements in self-rated sleep quality for jet lag. People with delayed sleep phase syndrome—a circadian rhythm disorder where natural sleep timing runs late—benefit from strategic melatonin timing to shift their internal clocks. Shift workers facing irregular schedules show similar advantages. Yale Medicine physicians recommend short-term use in small doses specifically for sleep onset issues, not ongoing insomnia disorders. Mayo Clinic experts acknowledge slight reductions in how long it takes to fall asleep, though effects on overall sleep quality and duration remain unclear. The pattern emerges clearly: melatonin works when addressing timing problems, not when trying to force sleep where circadian rhythms already align correctly.

Watch:

The Personal Responsibility Equation

Americans value freedom to make informed health choices, yet that freedom requires access to accurate information. The melatonin situation reveals how unregulated markets can fail consumers even when products remain legal and widely available. Billions of dollars flow annually into supplement sales despite quality control failures and mounting safety signals. The FDA’s limited authority over supplements creates a buyer-beware environment where individual research becomes essential. Reading clinical guidelines from organizations like the American Academy of Sleep Medicine, understanding the difference between short-term relief and chronic use, and recognizing that “natural” doesn’t guarantee “safe”—these represent basic due diligence. Consulting physicians before starting any supplement regimen, even over-the-counter options, aligns with both common sense and conservative principles of personal health stewardship. The evidence demands we question whether convenience and marketing should override medical guidance, especially when cardiovascular risks potentially outweigh modest sleep improvements for most users.

Sources:

The effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials
Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction
New study raises questions about long-term melatonin use
Study finds that melatonin content of supplements varies widely
5 Things to Know About Melatonin
Long-term use of melatonin supplements to support sleep may have negative health effects
Melatonin